Guardian Pharmacy Services (GRDN) officer donates 21,500 shares with lock-up

Rhea-AI Filing Summary

Guardian Pharmacy Services, Inc. Executive Vice President of Sales & Operations reported a charitable stock gift in this filing. On 12/04/2025, the insider made a bona fide gift of 21,500 shares of Class A common stock, recorded at a price of $0 as is typical for gifts. After this transaction, the reporting person beneficially owns 790,976 shares directly.

The shares were donated to a charitable donor-advised fund, which has agreed not to sell or transfer the shares during a lock-up period that runs until June 30, 2026. The filing is made by a single reporting person and reflects a transfer for charitable purposes rather than an open-market sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Forbes Kendall

(Last) (First) (Middle)

300 GALLERIA PARKWAY SE, SUITE 800

(Street)

ATLANTA GA 30339

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Guardian Pharmacy Services, Inc. [ GRDN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

3. Date of Earliest Transaction (Month/Day/Year)
12/04/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	12/04/2025		G		21,500(1)	D	$0	790,976	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a bona fide gift made by the Reporting Person to a charitable donor-advised fund (the "DAF"). The DAF has agreed not to sell or transfer the shares during a lock-up period expiring June 30, 2026.

Remarks:

Executive Vice President, Sales & Operations

	/s/ Douglas Towns, Attorney-in-Fact	12/08/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Guardian Pharmacy Services (GRDN) report in this Form 4?

The filing reports that an officer of Guardian Pharmacy Services, Inc. (GRDN) made a bona fide gift of 21,500 shares of Class A common stock on 12/04/2025.

Who is the reporting person in this GRDN Form 4 and what is their role?

The reporting person is an Executive Vice President, Sales & Operations of Guardian Pharmacy Services, Inc., identified in the filing as an officer of the issuer.

How many Guardian Pharmacy Services (GRDN) shares does the insider own after the reported gift?

Following the reported transaction, the insider beneficially owns 790,976 shares of Guardian Pharmacy Services Class A common stock in direct ownership.

What were the terms of the charitable gift in the GRDN Form 4?

The 21,500 shares were given as a bona fide gift to a charitable donor-advised fund, with the price shown as $0, which is standard for gift reporting.

Is there a lock-up period on the donated Guardian Pharmacy Services (GRDN) shares?

Yes. The donor-advised fund agreed that the donated shares will not be sold or transferred during a lock-up period expiring on June 30, 2026.

Does this GRDN Form 4 involve derivative securities or only common stock?

The filing’s reported transaction involves Class A common stock. The table for derivative securities is present but shows no derivative transactions in this excerpt.